LDL-cholesterol reduction in patients with hypercholesterolemia by modulation of adenosine triphosphate-citrate lyase and adenosine monophosphate-activated protein kinase
about
Lipid-Lowering Drug Therapy for CVD Prevention: Looking into the Future.Adenosine Monophosphate-Activated Protein Kinase (AMPK) as a Diverse Therapeutic Target: A Computational Perspective.Promising new therapies for the treatment of hypercholesterolemia.Progress in the care of common inherited atherogenic disorders of apolipoprotein B metabolism.Metabolic control of epigenetics in cancer.
P2860
LDL-cholesterol reduction in patients with hypercholesterolemia by modulation of adenosine triphosphate-citrate lyase and adenosine monophosphate-activated protein kinase
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
LDL-cholesterol reduction in p ...... phate-activated protein kinase
@ast
LDL-cholesterol reduction in p ...... phate-activated protein kinase
@en
LDL-cholesterol reduction in p ...... phate-activated protein kinase
@nl
type
label
LDL-cholesterol reduction in p ...... phate-activated protein kinase
@ast
LDL-cholesterol reduction in p ...... phate-activated protein kinase
@en
LDL-cholesterol reduction in p ...... phate-activated protein kinase
@nl
prefLabel
LDL-cholesterol reduction in p ...... phate-activated protein kinase
@ast
LDL-cholesterol reduction in p ...... phate-activated protein kinase
@en
LDL-cholesterol reduction in p ...... phate-activated protein kinase
@nl
P2093
P2860
P921
P1476
LDL-cholesterol reduction in p ...... phate-activated protein kinase
@en
P2093
Roger S Newton
Sergey Filippov
Stephen L Pinkosky
P2860
P304
P356
10.1097/MOL.0000000000000091
P5008
P577
2014-08-01T00:00:00Z